Laboratorios Biopas S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Laboratorios Biopas S.A. - overview
Established
2002
Location
Bogota, -, Colombia
Primary Industry
Biotechnology
About
Founded in 2002 and based in Bogota, Colombia, Laboratorios Biopas S. A. operates as a pharmaceutical company. In May 2024, Swixx Biopharma SA, a portfolio company of HBM Partners and Merieux Equity Partners, agreed to fully acquire Laboratorios Biopas Group.
The deal is subject to regulatory approvals and is expected to close in June–July 2024. As of 2024, the company had offices in Argentina, Brazil, Chile, Colombia, and Mexico. Laboratorios Biopas licenses, markets, and sells specialty pharmaceutical products to clients in the Latin American region.
Current Investors
Swixx Biopharma SA
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Specialty Pharmaceuticals
Website
www.biopasgroup.com
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Laboratorios Biopas S.A. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Laboratorios Biopas S.A. | - | ||||||||
| Private Debt | Completed | Laboratorios Biopas S.A. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.